Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure

Research output: Contribution to journalJournal articleResearchpeer-review

  • Karly C Sourris
  • Jasmine G Lyons
  • Sonia L Dougherty
  • Vibhasha Chand
  • Nora E Straznicky
  • Markus P Schlaich
  • Mariee T Grima
  • Mark E Cooper
  • Bronwyn A Kingwell
  • Maximilian de Courten
  • Josephine M Forbes
  • Barbora de Courten
Abstract Background: High levels of circulating advanced glycation end products (AGEs) can initiate chronic low-grade activation of the immune system (CLAIS) with each of these factors independently associated with cardiovascular (CV) morbidity and mortality. Therefore, our objective was to characterize the relationship between serum AGEs, CLAIS and other risk factors for CV disease in normotensive non-diabetic individuals. Methods: We measured body mass index (BMI), waist-to-hip ratio (WHR), blood pressure, lipid and glucose profile in 44 non-diabetic volunteers (17 female, 27 males). Carboxymethyl-lysine (CML) was measured by ELISA as a marker for circulating AGEs and NF-κB p65 activity as an inflammatory marker by DNA-binding in peripheral blood mononuclear cells lysates (PBMC). Results: Plasma CML concentrations were related to diastolic blood pressure (r=-0.51, p
Original languageEnglish
JournalClinical chemistry and laboratory medicine : CCLM / FESCC
Volume52
Issue number1
Pages (from-to)129-138
Number of pages10
DOIs
Publication statusPublished - 23 Mar 2013

ID: 46066727